570 556 captures · dernière capture : 3 mai 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
386 223 captures · dernière capture : 14 avr. 2026
243 880 captures · dernière capture : 28 avr. 2026
Policies Policy documents are interpretations of the purpose and intent of the Food and Drugs Act and Regulations. Notice: Application of the definition of Canadian Reference Product [2024-01-26] Policy statement: Use of pharmacometrics in drug submissions and clinical trial…
Notice: Re: Category IV / Labelling Standards Submission Application Process Review December 19, 2006 (PDF Version - 65 K) Contact: BGIVD Enquiries Notice Our file number: 06-129002-483 Re: Category IV / Labelling Standards Submission Application Process Review Category IV…
Submissions Containing Clinical Data from Studies Conducted outside of Canada Contact: Bureau of Policy, Science and International Programs Enquiries June 5, 2009 Notice Our file number: 09-114651-928 Submissions Containing Clinical Data from Studies Conducted outside of Canada…
Notice - Regulatory Cooperation Council (RCC) Over-the-Counter (OTC) Products - Common Monograph Working Group - Selection of a Monograph for Alignment (PDF Version - 18 K) January 10, 2013 Our file number: 12-122540-781 Health Canada is pleased to announce the launch of the…
Notice - Reconsideration of Decisions Issued for Human Drug Submissions April 1st Notice Our file number: 15-103791-905 Release of the revised: Guidance Document: Reconsideration of Decisions Issued for Human Drug Submissions Health Canada is pleased to announce the release of…
Notice - Release of the Final Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience) (PDF Version - 32 K) May 1, 2015 Notice Our file number: 15-104593-161 Release of the Final Guidance Document: Drug Submissions Relying on Third-Party…
Updates to the Guidance Document: Labelling of Pharmaceutical Drugs for Human Use September 15, 2015 Our file number: 15-109734-699 Notice On June 19, 2013, Health Canada published in Canada Gazette , Part II amendments to the Food and Drug Regulations . The Regulations Amending…
Notice: Updates to the Guidance Document: Fees for the Review of Drug Submissions and Applications November 6, 2015 Our file number: 15-111707-967 On July 2, 2014, Health Canada published in the Canada Gazette , Part II, the Regulations Amending the Food and Drug Regulations…
Notice - Antimicrobials Product Labelling November 16, 2015 Our reference number: 15-112507-157 Responding to the threat of Antimicrobial Resistance (AMR) has been at the forefront of recent international discussions due to the increasing concern of resistance to antibiotics for…
Update: Implementation of Plain Language Revisions to Part III: Patient Medication Information and Associated Templates of the Guidance Document: Product Monograph November 20, 2015 Our reference number: 15-111865-364 In April 2014, Health Canada announced the final release of…
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
